Tweet
https://ascopubs.org/doi/full/10.1200/JCO.20.01307
Full text at link.
DOI: 10.1200/JCO.20.01307 Journal of Clinical Oncology
Chemotherapy and COVID-19 Outcomes in Patients With Cancer
...
CONCLUSION
Recent cytotoxic chemotherapy treatment was not associated with adverse COVID-19 outcomes. Patients with active hematologic or lung malignancies, peri–COVID-19 lymphopenia, or baseline neutropenia had worse COVID-19 outcomes. Interactions among antineoplastic therapy, cancer type, and COVID-19 are complex and warrant further investigation.
Chemotherapy and COVID-19 Outcomes in Patients With Cancer
...
CONCLUSION
Recent cytotoxic chemotherapy treatment was not associated with adverse COVID-19 outcomes. Patients with active hematologic or lung malignancies, peri–COVID-19 lymphopenia, or baseline neutropenia had worse COVID-19 outcomes. Interactions among antineoplastic therapy, cancer type, and COVID-19 are complex and warrant further investigation.